NCAM1 and COVID-19: As shown in Table 3, CD8+CD3+CD45+ (p = 0.011), CD56+CD45+ (p < 0.0001), and CD56+CD15+CD45+ (p < 0.0001) cells were significantly decreased in COVID-19 patients when compared with healthy controls.